Journal of Pharmacy Practice and Research最新文献

{"title":"Vale Amy McRae","authors":"Michael J. Dooley BPharm, GradDipHospPharm, PhD, FSHP, AdvPracPharm","doi":"10.1002/jppr.1879","DOIUrl":"10.1002/jppr.1879","url":null,"abstract":"<p>This issue of the <i>Journal</i> includes a paper titled ‘Time for change: Improving neuromuscular blocking agent safety in Australia’.<span>¹</span> The lead author, Amy McRae, sadly passed away last year on 15 December, at home peacefully with her family by her side.</p><p>Amy had a passion and determination to improve the safe use of medicines and this influenced the many pharmacists, nurses, doctors, and patients who had the pleasure of interacting with her during her career. This included in her early role as a clinical pharmacist, through to more recently as Senior Medication Safety Pharmacist at Alfred Health. In addition, Amy was also the Senior Pharmacist, Quality Use of Medicines, Western Health and Senior Lecturer, Post-Graduate Studies and Professional Development Unit, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University.</p><p>Her contribution to improving the care of patients and reducing the risks associated with medication will be one of her many legacies. Amy was central in Australia-wide improvements to reduce neuromuscular blocking agent (NMBA) administration errors, which can cause unintended paralysis, respiratory arrest, severe permanent harm, and death. These endeavours included the publication of a national report <i>Time for change: proposed improvements to the labelling and packaging of neuromuscular blocking agents in Australia</i>.<span>²</span> This work, supported by the Victorian Therapeutics Advisory Group and many other national organisations, resulted in the introduction of mandatory warning statements for the labels of NMBAs in Australia. Amy was also pivotal in a range of other initiatives, including reducing potentially fatal errors associated with high doses of insulin, the introduction of Tall Man lettering to reduce medication selection errors, and patient education and empowerment strategies to improve prophylaxis for venous thromboembolism.</p><p>We are very saddened that Amy is not here to share in this milestone but know that her impact and legacy will continue. Amy was a wonderful person whose courage and determination to live a full life was inspirational to many of us who knew her. Amy will continue to be missed by many and her impact on making care safer will be felt far into the future.</p><p>The author complies with the <i>Journal's</i> authorship policy.</p><p>Michael Dooley is the Editor-in-Chief of the <i>Journal of Pharmacy Practice and Research</i>.</p><p>Ethics approval was not required for this announcement.</p>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"53 4","pages":"153-154"},"PeriodicalIF":2.1,"publicationDate":"2023-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1879","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44701010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Testing a medicine information needs identification tool (MINI-Q) with hospital inpatients in New Zealand","authors":"Trudi Aspden BPharm(Hons), PhD,&nbsp;Michelle Honey RN, PhD,&nbsp;Sarah Sneyd BA, BHSc, MPH,&nbsp;Kim Brackley DipPharm(Dist), PGDipHighE, MScClinPharm,&nbsp;Alana Cavadino BSc, MSc, PhD,&nbsp;Rosalie Chang BPharm, PGCert,&nbsp;Amy HY Chan BPharm(Hons), PhD","doi":"10.1002/jppr.1877","DOIUrl":"10.1002/jppr.1877","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Determining an individual's medicines information preferences and needs could enable health professionals to deliver more effective medicines information and help build patients' health literacy and ability to self-manage their health.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>This descriptive, cross-sectional study aimed to test a new information needs assessment tool, the Medicine Information Needs for Individuals – Questionnaire (MINI-Q), which elicits what individuals want to know about their medicines. This study aimed to explore the face validity, acceptability, and feasibility of using the tool in a hospital inpatient setting.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>Ethical approval was obtained from Health and Disability Ethics Committees (Reference no: 18/NTA/137). Following ethical approval, adult hospital inpatients from two service divisions in one large urban hospital in New Zealand were invited to self-assess their medicines information needs using the 23-item MINI-Q via a tablet or on paper. Descriptive statistics were generated from the quantitative data and responses to a free-text question were inductively analysed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The MINI-Q was completed by 228 inpatients, 137 (60%) of whom used a tablet. Participants requested information on 80.6% of the possible topics. The most common topic that participants wanted information about was possible side effects (92%). No additional topics to include in the MINI-Q were identified from the free-text responses. The median completion time of the tablet version was 9.2 min (interquartile range 6.7–14.6).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The MINI-Q shows promise to efficiently identify an individual's medicines information needs in an inpatient setting. The findings reinforce that most people want to know all the basic information about their medicines, with side effects being particularly important.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"53 5","pages":"248-255"},"PeriodicalIF":2.1,"publicationDate":"2023-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1877","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43235465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Elective surgery cancellations due to suboptimal medicine management: a retrospective single site study","authors":"Kate Elizabeth Doreen Ziser BPharm, GradDdpEd APP[II], MClinPharm,&nbsp;Jessica Barbara King BPharm,&nbsp;Natasha Alkass BPharm,&nbsp;Jane Elizabeth Dunsdon BPharm, BNursing APP[II]","doi":"10.1002/jppr.1876","DOIUrl":"10.1002/jppr.1876","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Elective surgery cancellations and delays are associated with negative financial and staffing ramifications, adverse clinical outcomes, and poor patient outcomes. The Princess Alexandra Hospital in Brisbane, Australia, performs approximately 15 000 elective surgeries per year and medication optimisation is pivotal in preparing a patient for surgery to avoid same day of surgery theatre cancellations. Ideally, patients are seen in a multidisciplinary pre-admission clinic for optimisation of their health and medicines, and to provide education regarding their surgery.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>To calculate the incidence of elective surgery cancellations due to medication misadventure over a 12-month period.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>A retrospective audit at a tertiary Queensland Hospital was conducted over a 12-month period (April 2021–March 2022), including patients who had their elective surgeries cancelled. The medical records from the hospital's digital databases for patients who were identified by the hospital coding service as ‘unfit for surgery’ were screened to see if the reason for the surgery cancellation was due to medication misadventure. The project was reviewed by the Metro South Human Research Ethics Committee and deemed exempt from further review (Ref No: CM20221651).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The surgery cancellation rate was 50% (<i>n</i> = 6626 cancelled surgeries from 13 255 total surgeries booked). The same day of surgery cancellation rate was 5.5% (<i>n</i> = 734). Medication misadventure resulting from suboptimal medicine management was responsible for 1% (<i>n</i> = 66 out of 6626 surgery cancellations). A total of 41% (<i>n</i> = 27) of patients had their surgery cancelled ahead of time by the pharmacist due to a medication not being withheld for long enough, which prevented a same-day cancellation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Having a pre-admission clinic pharmacist improves preoperative medication optimisation and has been proven to avoid same-day cancellations.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"53 5","pages":"256-261"},"PeriodicalIF":2.1,"publicationDate":"2023-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44965570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Standard of practice in mental health for pharmacy services","authors":"Helen Lowy BSc (Hons), PGDipClinPharm, MPhil, PGDipCounselling, FSHP,&nbsp;Viandro Borja BPharm (Hons), GradCertPharmPrac, MClinPharm, MSHP,&nbsp;Stewart Bailey BPharm, DipMgt, MPS, MSHP,&nbsp;Cecilia Bjorksten BPharm, MPS, MSHP, FACP, AACPA,&nbsp;Alice Kochman BPharm, MClinPharm, MSHP,&nbsp;Judy Longworth BPharm, MPharm (Clin), FSHP,&nbsp;Alistair Meldrum BPharm (Hons), MClinPharm, MSHP,&nbsp;Amy Sieff BBiomedSc, MPharm, GradCertLShip (HlthHumServ), MSHP,&nbsp;Lesley Smith BPharm, AdvPP (II), BCPP, MSHP,&nbsp;Alice Wisdom BPharm (Hons), MSHP,&nbsp;Yee Mellor BPharm, MCncrSc, GPhC, MSHP","doi":"10.1002/jppr.1874","DOIUrl":"10.1002/jppr.1874","url":null,"abstract":"Standard of practice in mental health for pharmacy services Helen Lowy, BSc (Hons), PGDipClinPharm, MPhil, PGDipCounselling, FSHP*, Viandro Borja, BPharm (Hons), GradCertPharmPrac, MClinPharm, MSHP, Stewart Bailey, BPharm, DipMgt, MPS, MSHP, Cecilia Bjorksten, BPharm, MPS, MSHP, FACP, AACPA, Alice Kochman, BPharm, MClinPharm, MSHP, Judy Longworth, BPharm, MPharm (Clin), FSHP, Alistair Meldrum, BPharm (Hons), MClinPharm, MSHP, Amy Sieff, BBiomedSc, MPharm, GradCertLShip (HlthHumServ), MSHP, Lesley Smith, BPharm, AdvPP (II), BCPP, MSHP, Alice Wisdom, BPharm (Hons), MSHP, Yee Mellor, BPharm, MCncrSc, GPhC, MSHP 1 Mental Health Leadership Committee, The Society of Hospital Pharmacists of Australia, Abbotsford, Victoria, Australia 2 Helen Lowy Counselling and Psychotherapy, Frankston South, Victoria, Australia 3 Pharmacy Department, Alfred Health, Melbourne, Victoria, Australia 4 Faculty of Pharmacy and Pharmaceutical Science, Monash University, Parkville, Victoria, Australia 5 Pharmacy Department, Darling Downs Health, Toowoomba, Queensland, Australia 6 Hunter New England Mental Health Service, Waratah, New South Wales, Australia 7 Pharmacy Department, Austin Health, Heidelberg, Victoria, Australia 8 The Children’s Hospital at Westmead, Sydney Children’s Hospital Network, Sydney, NSW, Australia 9 Rockhampton Hospital Pharmacy Department, Central Queensland Hospital and Health Service, Rockhampton, Queensland, Australia 10 South Western Sydney Local Health District, Warwick Farm, New South Wales, Australia 11 Pharmacy Department, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia 12 SA Pharmacy, SA Health, Adelaide, South Australia, Australia 13 The Society of Hospital Pharmacists of Australia, Abbotsford, Victoria, Australia","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"53 4","pages":"204-225"},"PeriodicalIF":2.1,"publicationDate":"2023-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43683921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A review of pharmacy-led interventions: identification of facilitators and barriers for the design of a new model of care for asthma","authors":"Neera Rajballi-Naidoo BSC.Pharm, PGDipHS, MHSc,&nbsp;Kyle John Wilby PharmD, PhD,&nbsp;Amber Young BPharm, PGCertPharm, PGCertGPP, PhD,&nbsp;Alesha Smith BSc, MSc, PhD, MBA","doi":"10.1002/jppr.1870","DOIUrl":"10.1002/jppr.1870","url":null,"abstract":"<p>The objective of this narrative review was to determine the facilitators and barriers identified in pharmacy-led interventions that improve outcomes in patients with asthma and support the implementation of interventions in practice. EMBASE, Web of Science, Google Scholar, and PubMed were used to identify 17 relevant articles. Seven studies were randomised controlled studies and 10 were one-arm, pre-post evaluations of all participants enrolled. Questionnaires assessing asthma control, medicine adherence, and knowledge about asthma were used, while checklists were used to assess inhaler technique. Studies with planned interventions in a clinic or general practice setting and lasting for 6 months (compared to longer interventions of 48 weeks) were more successful in retaining participation in the program. Education was the key intervention in which inhaler technique training was the most common. Knowledge about the disease, its aetiology, trigger factors, and medication used were covered in 10 of the studies. Fifteen of the articles reported an improvement in the asthma of patients receiving intervention by the pharmacist, measured by their asthma control test scores, emergency department visits, or reduced emergency steroid prescriptions. This review highlights five key requirements for the success of pharmacy-based interventions for asthma management: (a) developing and maintaining a skilled workforce; (b) close proximation of a general practitioner practice or clinic to the pharmacy; (c) patient education on the disease and medicine; (d) structured and standardised intervention and assessment; and (e) length of the intervention suitable to the pharmacist and the patient.</p>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"53 5","pages":"227-240"},"PeriodicalIF":2.1,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1870","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45639474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacist ambulatory pain services for a chronic non-cancer pain clinic: a descriptive study","authors":"Sam Maleki BPharm, MPharmPrac,&nbsp;Jeremy Szmerling BPharm,&nbsp;Mahisha Thiruvasagan BPharm, MPharmPrac,&nbsp;Gloria Seah FFPMANZCA, FANZCA, MMed(Periop), MBBS,&nbsp;Galahad Gu BPharm(Hons), MPharmPrac","doi":"10.1002/jppr.1875","DOIUrl":"10.1002/jppr.1875","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Patients presenting to specialist pain clinics are often prescribed complex and high-risk analgesic regimens. In this setting, pharmacists can help identify at risk patients and provide valuable clinical input to improve patient outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>To evaluate the role of a clinical pharmacist in improving the triage, assessment and management of patients presenting to ambulatory pain clinics.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>This descriptive study enrolled patients from two chronic noncancer pain clinics from July to December 2021. A new clinical pharmacist service was devised, which operated as telehealth one day per week. The pharmacist was responsible for accepting referrals, triaging based on clinic criteria and updating them with prescription risk factors, in line with SafeScript's traffic light system. Pharmacist clinical services included completion of medication histories, drug dose interventions and patient education. This project received departmental ethical approval from the Eastern Health Office of Research and Ethics prior to commencement (Approval No: QA21-068).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The pharmacist assessed 253 patients and identified prescription risk factors for 68 patients; of which 11 (16%) had received opioids from ≥4 prescribers, 10 (15%) were issued a monitored prescription from ≥4 pharmacies, seven (10%) were on high-risk drug combinations, 25 (37%) had an Oral Morphine Equivalent Daily Dose (OMEDD) of 50–100 mg, and 26 (38%) with OMEDD &gt;100 mg. The pharmacist completed 67 medication histories and provided 22 accepted drug intervention recommendations to clinic physicians, including seven recommendations for dose adjustments, six to cease a medicine and nine to start a new medicine.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The pharmacist incorporated SafeScript in the clinics' triage processes and provided valuable clinical interventions complementing the care provided by the pain physicians and the allied health staff.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"53 5","pages":"241-247"},"PeriodicalIF":2.1,"publicationDate":"2023-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42258986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Forgotten but not gone: calcium-alkali syndrome","authors":"Shrey Seth Pharm D,&nbsp;Lukas Kairatis MBBS, FRACP, PhD,&nbsp;Ronald L. Castelino BPharm, MPharm, PhD","doi":"10.1002/jppr.1873","DOIUrl":"10.1002/jppr.1873","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Calcium-alkali syndrome (CAS) is characterised by hypercalcaemia, metabolic alkalosis, and renal injury. CAS has been a long-standing concern but has fallen off the radar in recent times. However, supplementation of calcium and vitamin D for osteoporosis, and use of calcium based antacids for reflux has led to its resurgence as one of the leading causes for hypercalcaemia-induced hospitalisations.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>We present a case of CAS owing to excessive consumption of calcium carbonate in the presence of vitamin D.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Clinical details</h3>\u0000 \u0000 <p>An 84-year-old woman presented to the hospital emergency room for the second time in 4 months after CAS was missed during the first admission. A history of significant (6–8 tablets daily) Quick-Eze use (calcium carbonate), Gaviscon dual action antacid (calcium carbonate 32.5 mg/mL, sodium bicarbonate 21.3 mg/mL, sodium alginate 50 mg/mL) for reflux, and 2000 IU of vitamin D capsules for osteoporosis was the likely reason for CAS. COVID-19 lockdown and the inability to fill esomeprazole scripts had increased the patient's reliance on over-the-counter treatments for reflux.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Outcomes</h3>\u0000 \u0000 <p>The severe hypercalcaemia was treated using intravenous fluids and pamidronate, following which her serum calcium levels normalised, with resolution of symptoms.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The effect of Quick-Eze tablets on the development of hypercalcaemia should not be underestimated, especially in the presence of interacting medicines or supplements. This report highlights the importance of accurate history taking as the hypercalcaemia was missed during the patient's initial visit. Appropriate warning labels are warranted on Quick-Eze tablets, as the current information is ambiguous, with no specific information on duration.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"53 5","pages":"268-270"},"PeriodicalIF":2.1,"publicationDate":"2023-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1873","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45738278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Design and implementation of an electronic opioid management plan to support consistent communication of opioid analgesia prescribing intentions to patients and general practitioners","authors":"Elizabeth Su BPharm(Hons), GradCertPharmPrac, MPharmPrac, CHIA,&nbsp;Parnaz Aminian BPharm(Hons), GradCertPharmPrac,&nbsp;Christopher McMaster MBBS, BSc/BA, GradDipBiostats, CHIA, FRACP,&nbsp;Jade Eyles BPharm(Hons), MPharmPrac,&nbsp;Albert G. Frauman MBBS, MD, FRACP, FACCP, FACP,&nbsp;Kent Garrett BPharm, GradDipHospPharm,&nbsp;Simone E. Taylor BPharm, PharmD, GradCertClinResMeth,&nbsp;David F. L. Liew MBBS, FRACP, CHIA","doi":"10.1002/jppr.1872","DOIUrl":"10.1002/jppr.1872","url":null,"abstract":"<p>Opioid prescribing requires careful planning to minimise the risk of serious adverse outcomes. However, documentation of discharge opioid plans for patients and their general practitioners (GPs) is inconsistent, particularly when opioids are commenced in the emergency department or after surgery. We describe an initiative to promote consistent discharge opioid plan communication by implementing an opioid management plan (OMP) in our hospital's electronic medical record. Completion of an electronic form by the prescriber generates an OMP note in the medical history, which is used by the pharmacist to provide tailored opioid patient education. The OMP also populates the discharge summary that is sent to the GP and the Australian national digital health record platform, My Health Record. Preliminary evaluation shows incorporating OMP documentation into routine workflows has assisted prescribers to consistently document the plan for supplied opioids, supporting continuity of care. Workflow optimisation is ongoing to further improve discharge summary documentation and provision of patient-friendly written information. This study was conducted as a quality improvement project and audits conducted as part of the project were approved by Austin Health's Office for Research (Project No: LNR/18/Austin/155). Informed patient consent was not required by Austin Health.</p>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"53 4","pages":"186-194"},"PeriodicalIF":2.1,"publicationDate":"2023-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48830165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluating the patient-perceived impact of a neratinib special access program in an Australian community pharmacy","authors":"Jessie Zhang,&nbsp;Lynn Cheong BPharm, PhD","doi":"10.1002/jppr.1871","DOIUrl":"10.1002/jppr.1871","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>In Australia, breast cancer is the most commonly diagnosed cancer in women, and improved survival rates have placed an increased burden on the healthcare system. To better utilise community pharmacists in anticancer therapy, a medicine management service for neratinib was initiated in an Australian community pharmacy for patients with breast cancer.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>To explore the experience and satisfaction of Australian breast cancer patients who received a pharmacist medicine management service for their neratinib treatment through a community pharmacy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>Patients enrolled in the neratinib special access program were invited to complete an electronic survey between February–September 2019. A mixed-methods approach was utilised in data analysis. Ethics approval was granted by the University of Canberra Human Research Ethics Committee (Project No: 20181648).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Thirty-three individuals completed the survey. A majority of participants (94%) were either ‘very satisfied’ or ‘satisfied’ with the time the pharmacist spent with them. As part of the service, 88% of participants viewed the first pharmacist session as ‘absolutely’ worthwhile and 79% believed that the pharmacist interaction increased their understanding of neratinib therapy. Many participants supported the continued provision and expansion of the service (88%).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This pilot study provided valuable insights into participants' experiences of a pharmacist medicine management service for neratinib therapy. The unique preferences and health information needs of patients were highlighted. Further investigation is needed to explore how community pharmacists may be best utilised to improve breast cancer care and support patient needs.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"53 4","pages":"177-185"},"PeriodicalIF":2.1,"publicationDate":"2023-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1871","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44650495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Overview of factors influencing successful implementation of non-medical prescribing","authors":"Mariam Ghabour BPharm, MQM,&nbsp;Kyle John Wilby PharmD, PhD,&nbsp;Caroline J. Morris BPharm (Hons), MSc, PhD,&nbsp;Alesha J. Smith BSc, MSc, MBA, PhD","doi":"10.1002/jppr.1868","DOIUrl":"10.1002/jppr.1868","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>This study sought to determine the factors influencing successful implementation of non-medical prescribing (NMP).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data sources</h3>\u0000 \u0000 <p>EMBASE, Medline, CINAHL and reference lists were searched from January 2010 to November 2020.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Study Selection</h3>\u0000 \u0000 <p>Umbrella review and narrative synthesis of results were utilised. The retrieved reviews underwent title screening, abstract review, full-text screening and assessment for inclusion. To guarantee the precision of the search results, Participants, Intervention, Control, and Outcomes (PICO) elements were recorded for each study. Studies were included if they were systematic reviews, published in English, published from January 2010 to November 2020, and discussed barriers and/or facilitators to NMP implementation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of the 193 studies identified, eight were eligible for inclusion. Most of the reviews (62%) were published in 2017–2018. The majority of the reviews (62%) were focused on the United Kingdom. Three reviews discussed nurse prescribing, two reviews focused on pharmacist prescribing, and three reviews investigated NMP generally. Data were compiled into the Consolidated Framework for Implementation Research to evaluate the factors that influence the success or failure of NMP implementation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Implementation of NMP is a complex process which requires fulfilment of all its elements. The success of NMP can be directly related to the extent of the whole system engagement and support, and available funding.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"53 4","pages":"155-170"},"PeriodicalIF":2.1,"publicationDate":"2023-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1868","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47273155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}